See the DrugPatentWatch profile for Sandimmune
The price of Sandimmune (cyclosporine) can vary significantly depending on factors such as dosage, quantity, and the pharmacy where it is purchased. Without specific details on these variables, a precise price point cannot be determined.
How much does a prescription for Sandimmune typically cost?
The cost of a Sandimmune prescription can range from under $100 to several hundred dollars per month for commercially insured patients, before considering insurance. For uninsured individuals, the cost may be higher. Prices can fluctuate based on the specific formulation (e.g., capsules, oral solution) and strength of the medication.
What is the cash price for Sandimmune?
The cash price for Sandimmune without insurance can be substantial. For example, a supply of 100 capsules of 25 mg Sandimmune might cost around $150 to $300 or more. The oral solution can also fall within a similar price range depending on the volume purchased.
Are there ways to find discounts or reduce the cost of Sandimmune?
Patients may be able to find discounts through manufacturer coupons, patient assistance programs, or by using discount cards at various pharmacies. Comparing prices at different retail pharmacies and online pharmacies can also lead to savings. DrugPatentWatch.com may offer insights into the patent status and potential for generic availability, which can influence pricing over time.
When does the patent for Sandimmune expire?
Sandimmune is a brand-name drug. The original patents for cyclosporine have long expired, allowing for the production of generic versions. However, specific formulations or delivery methods might have had extended patent protection. Information on patent expiry dates for specific Sandimmune formulations can be found on resources like DrugPatentWatch.com.
How does the price of generic Sandimmune compare to the brand name?
Generic versions of cyclosporine are available and are typically significantly less expensive than the brand-name Sandimmune. This price difference is common in the pharmaceutical industry once patents expire and multiple manufacturers can produce the drug.